Xenetic Biosciences, Inc. - Common Stock (XBIO)
6.3300
-3.1300 (-33.09%)
NASDAQ · Last Trade: Oct 12th, 6:51 AM EDT
Benzinga Edge Stock Rankings evaluate companies across four key factors. Here are three big companies that stood out this week.
Via Benzinga · October 10, 2025
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · October 10, 2025
Via Benzinga · October 10, 2025
Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · October 10, 2025

Via Benzinga · May 16, 2023
Healthcare and biotech stocks have lagged broader markets this year, but a growing number of names have been picking up steam as the market rally broadens and major indexes continue to reach new highs. Here's a look at four stocks flashing strong momentum signals.
Via Benzinga · October 9, 2025
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · October 9, 2025
Via Benzinga · October 9, 2025
Via Benzinga · October 8, 2025
Via Benzinga · October 8, 2025
Via Benzinga · October 8, 2025
Via Benzinga · October 8, 2025
Via Benzinga · June 30, 2025
Via Benzinga · June 23, 2025

Via Benzinga · September 30, 2024

XBIO stock results show that Xenetic Biosciences met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 13, 2024

XBIO stock results show that Xenetic Biosciences beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 9, 2024

XBIO stock results show that Xenetic Biosciences beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 22, 2024

Via Benzinga · December 5, 2023
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Gainers
Via Benzinga · June 20, 2023

Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
Via Benzinga · May 15, 2023

U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeking to block the entirety of Kacsmaryk's order suspending the FDA approval of the abortion pill mifepristone.
Via Benzinga · April 13, 2023

A U.S. federal appeals court has temporarily blocked a decision by a Texas judge to halt the FDA's approval of a widely used abortion drug.
Via Benzinga · April 13, 2023